Latest news
BofA Spends Over 350 Billion Won Yearly on Employee Weight-Loss Drugs - Seoul Economic DailySeoul Economic Daily · Sun, 09 Aug 2026 02:08:16 GMTGedeon Richter Bets on the Billion-Dollar Weight-Loss Drug Market - Hungary TodayHungary Today · Fri, 07 Aug 2026 13:54:58 GMTLilly's Mounjaro, Zepbound sales surge, widening lead over Novo Nordisk - ET PharmaET Pharma · Thu, 06 Aug 2026 00:21:33 GMTBank of America CEO Says The Company Spends $250 Million A Year on GLP-1 Drugs for Their Employees. He Calls It a Good Investment - International Business TimesInternational Business Times · Wed, 05 Aug 2026 23:20:01 GMTLilly's GLP-1 Drugs Just Blew Sales Expectations Out Of The Water - Investor's Business DailyInvestor's Business Daily · Wed, 05 Aug 2026 20:07:00 GMTWeight-loss drug boom widens Lilly’s lead over Novo | 2026-08-05 | Investing News - StockhouseStockhouse · Wed, 05 Aug 2026 19:27:32 GMTLilly beats estimates on resilient demand for injectable GLP-1 drugs, widens gap with Novo - ReutersReuters · Wed, 05 Aug 2026 17:51:09 GMTLilly’s obesity pill Foundayo ‘disappointed’ in Q2, as injectables continue to boom - Fierce PharmaFierce Pharma · Wed, 05 Aug 2026 15:42:35 GMT